Additional speaker information is forthcoming. Click on a name below to jump to a particular speaker.


Dr. Orn Almarsson
Senior Vice President and Head of Formulation
Moderna Therapeutics


↑ Return to Top


Dr. Daniel Anderson
Samuel A Goldblith Professor of Applied Biology, Chemical Engineering and Health Sciences and Technology
MIT

↑ Return to Top


Dr. Tatiana Bronich
Professor & Co-Director, Center for Drug Delivery and Nanomedicine
UNMC


↑ Return to Top


Dr. Yizhou DongDr. Yizhou Dong
Asst Professor, Pharm CBO/Coll;
Asst Professor, Radiation Oncology
Ohio State University

Biography:
Yizhou Dong received his B.S. from Peking University, Health Science Center (2002) and M.S. from Shanghai Institute of Organic Chemistry (2005). In 2009, he received his Ph.D. in pharmaceutical sciences from the University of North Carolina at Chapel Hill under the supervision of Professor K.-H. Lee. From 2010 to 2014, he was a postdoctoral fellow in the laboratory of Professors Robert Langer and Daniel Anderson at MIT. Dr. Dong joined OSU College of Pharmacy as an Assistant Professor in 2014, and was promoted to Associate Professor in 2018. His research focuses on the design and development of nanotechnology platforms for the treatment of genetic disorders, infectious diseases, and cancers. Dr. Dong has authored over fifty papers and patents. Several of his inventions have been licensed and are currently under development as drug candidates for clinical trials. He is the recipient of numerous honors, including Early Career Investigator Award from the Bayer Hemophilia Awards Program, Research Awards from the National PKU Alliance, New Investigator Grant from the AAPS Foundation, Maximizing Investigators’ Research Award from the National Institute of General Medical Sciences (NIGMS), and 2017 Ohio State Early Career Innovator of the Year.

↑ Return to Top


Dr. Laird Forrest
Associate Professor
Kansas University


↑ Return to Top


Dr. Jinming Gao
Professor
UT Southwestern


↑ Return to Top


Dr. GhandehariDr. Hamid Ghandehari
Professor, Departments of Pharmaceutics and Pharmaceutical Chemistry and Bioengineering, University of Utah
Director of Utah Center for Nanomedicine
Co-Founder and Co-Director of the Nano Institute of Utah
Director of the University of Utah Nanotechnology Training Program.

Biography:
Hamid Ghandehari is a Professor at the Departments of Pharmaceutics and Pharmaceutical Chemistry and Bioengineering, Director of Utah Center for Nanomedicine and Co‐Founder and Co‐Director of the Nano Institute of Utah at the University of Utah. His research focuses on the design of recombinant polymers for gene and drug delivery, targeted delivery of polymer therapeutics to solid tumors, oral delivery of chemotherapeutics, and assessing the biocompatibility of silica and dendritic nanoconstructs. Dr. Ghandehari is Editor in Chief of Advanced Drug Delivery Reviews, Fellow of the American Institute for Medical and Biological Engineering, the American Association of Pharmaceutical Scientists and the Controlled Release Society. He serves on the scientific advisory boards of several national and international drug delivery organizations such as the Controlled Release Society. He has published over 175 articles, and given over 230 invited talks. He received his BS in Pharmacy and PhD in Pharmaceutics and Pharmaceutical Chemistry from the University of Utah.


↑ Return to Top


Dr. Joe Gray
Professor and Gordon Moore Endowed Chair, Dept of Biomedical Engineering;
Director, OHSU Center for Spatial Systems Biomedicine;
Associate Director for Biophysical Oncology, Knight Cancer Institute
OHSU

↑ Return to Top


Dr. Markus Grompe
Professor of Pediatrics School of Medicine
Ray Hickey Chair of the of Pape’ Family Pediatric Research Institute, Pediatrics School of Medicine
Molecular and Medical Genetics Graduate Program, School of Medicine
Cancer Biology Graduate Program, School of Medicine
Program in Molecular and Cellular Biosciences, School of Medicine
OHSU

↑ Return to Top


Dr. Paulina Hill
Principal Healthcare Investor
Polaris Venture Capital

↑ Return to Top


Dr. Muthusamy Jayaraman
Director
Alnylam

↑ Return to Top


Dr. JokerstDr. Jesse Jokerst
Asst Professor, Dept of Nanoengineering
UCSD

Biography:
Jesse V. Jokerst is an Assistant Professor in the Department of NanoEngineering at UC San Diego. Dr. Jokerst graduated cum laude from Truman State University (Kirksville, Missouri) in 2003 with a B.S. in Chemistry and completed a Ph.D. in Chemistry at The University of Texas at Austin in 2009 with John T. McDevitt. Jesse was a postdoc with Sam Gambhir at Stanford Radiology from 2009-2013 and was an Instructor in that same department from 2013-2015. At Stanford, Jesse received a prestigious American Cancer Society Postdoctoral Fellowship, a Burroughs Wellcome Collaborative Research Training Grant, and an NIH R25 Postdoctoral Fellowship. Jesse started at UCSD in July of 2015, and his research focuses on novel chemical probes as acoustic contrast agents. He is currently funded under the NIH’s K99/R00 Pathway to Independence and New Innovator Awards.

↑ Return to Top


Dr. Alexander Kabanov
Director, Center for Nanotechnology inDrug Deliver;
Mescal S Ferguson Distinguished Professor;
Co-Director Carolina Institute for Nanomedicine;
Adjunct Professor of Biomedical Engineering
UNC-Chapel Hill

↑ Return to Top


Dr. Ali Khademhosseini
Professor, Dept of Bioengineering, Dept of Radiology, Dept of Chemical and Biomolecular Engineering
UCLA

↑ Return to Top


Dr. Glen KwonDr. Glen Kwon
Professor
University of Wisconsin

Biography:
Dr. Glen S. Kwon is the Jens T. Carstensen Professor in the School of Pharmacy at the University of Wisconsin. He received a B.S. in Chemistry in 1986 and Ph.D. in Pharmaceutics in 1991 from the University of Utah. He was a Japan Society for the Promotion of Science Postdoctoral Fellow at the Institute of Advanced Biomedical Engineering and Science at Tokyo Women’s Medical University in Tokyo, Japan from 1991 to 1993 and an Assistant Professor in the Faculty of Pharmacy and Pharmaceutical Sciences at the University of Alberta in Edmonton, Canada from 1993 to 1997. He received the Jorge Heller Journal of Controlled Release/Controlled Release Society (CRS) Outstanding Paper Award in 1994 and the CRS Young Investigator Research Achievement Award in 2003. He was elected a Fellow of the American Association of Pharmaceutical Scientists in 2012. He was selected as a highly-cited researcher by Thomson Reuters in the category of Pharmacology & Toxicology in 2014. He is co-founder of Co-D Therapeutics Inc., a start-up company developing taxane-based nanomedicines. He serves on editorial boards of J. Controlled Release, Molecular Pharmaceutics, and Pharm. Res. His research focuses on pharmaceutical nanotechnology for drug, gene and peptide/protein-based therapeutics.

↑ Return to Top


Dr. Gabriel Kwong
Assistant Professor, Wallace H Coulter, Department of Biomedical Engineering
Georgia Tech


↑ Return to Top


Dr. Tamara Minko
Distinguished Professor Chair, Department of Pharmaceutics
Rutgers University


↑ Return to Top


Dr. Suzie Pun
Associate Professor, Department of Bioengineering
University of Washington

Biography:
Suzie H. Pun is the Robert F Rushmer Professor of Bioengineering, an Adjunct Professor of Chemical Engineering, and a member of the Molecular Engineering and Sciences Institute at UW. She is a fellow of the National Academy of Inventors (NAI) and American Institute of Medical and Biological Engineering (AIMBE), and has been recognized with MIT Technology Review’s “Top 100 Young Innovators” designation, the Presidential Early Career Award for Scientists and Engineers in 2006, the 2014 Young Investigator Award from the Controlled Release Society, and as an AAAS-Lemelson Invention Ambassador in 2015. She serves as an Associate Editor for ACS Biomaterials Science and Engineering. Her research focus area is in biomaterials and drug delivery.
Suzie Pun received her B.S. in Chemical Engineering from Stanford University and her Ph.D. in Chemical Engineering from the California Institute of Technology. She also worked as a senior scientist at Insert Therapeutics/Calando Pharmaceuticals developing polymeric drug delivery systems before joining the Department of Bioengineering at University of Washington.


↑ Return to Top


Dr. J RaoDr. Jianghong Rao
Professor of Radiology (Molecular Imaging Program at Stanford) and Chemistry
Stanford University

Biography:
Dr. Jianghong Rao received his BS in Chemistry from Peking University in 1991, a MS in chemistry from Rutgers, the State University of New Jersey, New Brunswick in 1994, and a PhD in Chemistry from Harvard University in 1999. After completing a Damon Runyon Cancer Research Foundation postdoctoral fellowship at UCSD with Professor Roger Y. Tsien in 2001, he joined the faculty of the Department of Molecular and Medical Pharmacology at UCLA as assistant professor. In 2004, he moved to Stanford University where he is currently a full Professor of Radiology and Chemistry (By courtesy). His general research interest is focused on developing new imaging strategies, molecular probes and nanoparticles to interrogate biological and medical problems.

↑ Return to Top


Dr. Jan Schnitzer
PRISM

↑ Return to Top


Dr. Avi SchroederDr. Avi Schroeder
Professor, Chemical Engineering
Technion Israel Institute of Technology

Biography:
Avi Schroeder is an Assistant Professor of Chemical Engineering at the Technion – Israel Institute of Technology where he heads the Laboratory for Targeted Drug Delivery and Personalized Medicine Technologies which focuses on developing nanotechnologies for precision medicine (https://www.schroederlab.com/). Dr. Schroeder conducted his Postdoctoral studies at the Massachusetts Institute of Technology, and his PhD at the Hebrew and Ben Gurion Universities. Avi is the recipient of more than 25 national and international awards, including named a KAVLI Fellow, a Horev Fellow – Leaders in Science and Technology, an Alon Fellow as well as the Intel Nanotechnology-, TEVA Pharmaceuticals-, and the Wolf Foundation Krill Award. Avi is the author of more than 45 research papers inventor of 17 patents and co-founder of multiple startup companies based on these discoveries.

↑ Return to Top


Dr. Ankur Singh
Assistant Professor, Sibley School of Mechanical and Aerospace Engineering;
Assistant Professor, Meingig School of Biomedical Engineering
Cornell University


↑ Return to Top


Dr. Arturo Vegas
Assistant Professor, Chemistry
Boston University

↑ Return to Top


Dr. A WangDr. Andrew Z. Wang
Associate Professor
UNC – Chapel Hill

Biography:
Andrew Z. Wang, MD, is Associate Professor and Director of Clinical and Translational Research, Department of Radiation Oncology, UNC-Chapel Hill. He is also the co-Director of the Carolina Cancer Nanotechnology T32 training program. Dr. Wang earned his undergraduate degrees from Indiana University and medical degree from the HST program at Harvard Medical School. He completed his radiation oncology training in the Harvard Radiation Oncology Program. Following residency, Dr. Wang joined the UNC faculty in 2009. Dr. Wang’s research program is focused on the clinical translation of engineering sciences, including Nanomedicine, to oncology. His research spans a wide spectrum of translational research, from preclinical research to early phase clinical trials. He also co-founded Capio Biosciences, a biotech startup that is translating a nanotechnology-based circulating tumor cell capture assay.

↑ Return to Top


Dr. Liangfang Zhang
Professor, Department of Nanoengineering, Moores Cancer Center
USCD

↑ Return to Top